Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis — ADDUP

Hepatitis, Alcoholic Clinical Trial

Official title:
Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis

Status Active, not recruiting

Clinical Trial Summary

ADDUP is an observational study of patients with alcoholic hepatitis. A structured interview is used to quantitatively estimate:

1. Alcohol use

2. Dietary intake

3. Drug use (legal and illegal)

in the weeks preceding onset of acute alcoholic hepatitis. After interview patients are followed up for 12 months with regard to response to therapy and survival.

The study is intended to explore potential precipitants of alcoholic hepatitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02404636
Study type	Observational
Source	University Hospital Birmingham
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2012
Completion date	January 2018

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00205049` - Pentoxifylline for Acute Alcoholic Hepatitis (AAH)	Phase 1
Recruiting	`NCT04142723` - Alcoholic Hepatitis in Latin-America: A Prospective and Multicentric Study (AH-LATIN).
Completed	`NCT00913757` - A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Completed	`NCT01968382` - Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis	Phase 2
Recruiting	`NCT02024295` - Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis	Phase 4
Enrolling by invitation	`NCT04234139` - Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation